Antagonists of the vanilloid receptor subtype 1 (VR1) and use thereof
申请人:Gomtsyan Arthur
公开号:US20060281799A1
公开(公告)日:2006-12-14
The present invention is directed to compounds of formula (I)
wherein variables W, X, Y, D, A, n, R
1
, R
2
and R
9
are as defined in the description.
本发明涉及式(I)的化合物,其中变量W、X、Y、D、A、n、R1、R2和R9如描述中所定义。
ANTAGONISTS OF THE VANILLOID RECEPTOR SUBTYPE 1 (VR1) AND USE THEREOF
申请人:Gomtsyan Arthur
公开号:US20100010055A1
公开(公告)日:2010-01-14
The present invention is directed to compounds of formula (I)
wherein variables W, X, Y, D, A, n, R
1
, R
2
and R
9
are as defined in the description.
本发明涉及式(I)的化合物,其中变量W,X,Y,D,A,n,R1,R2和R9如描述中所定义。
Synthesis and biological evaluation of 5-substituted and 4,5-disubstituted-2-arylamino oxazole TRPV1 antagonists
作者:Richard J. Perner、John R. Koenig、Stanley DiDomenico、Arthur Gomtsyan、Robert G. Schmidt、Chih-Hung Lee、Margaret C. Hsu、Heath A. McDonald、Donna M. Gauvin、Shailen Joshi、Teresa M. Turner、Regina M. Reilly、Philip R. Kym、Michael E. Kort
DOI:10.1016/j.bmc.2010.04.099
日期:2010.7
The synthesis and structure-activity relationships of a series of 5-monosubstituted and 4,5-disubstituted 2-arylaminooxazoles as novel antagonists of the transient receptor potential vanilloid 1 (TRPV1) receptor are described. The 7-hydroxy group of the tetrahydronaphthyl moiety on the 2-amino substituent of the oxazole ring was important for obtaining excellent in vitro potency at the human TRPV1 receptor, while a variety of alkyl and phenyl substituents at the 4- and 5-positions of the oxazole ring were well tolerated and yielded potent TRPV1 antagonists. Despite excellent in vitro potency, the 5-monosubstituted compounds suffered from poor pharmacokinetics. It was found that 4,5-disubstitution on the oxazole ring was critical to the improvement of the overall pharmacokinetic profile of these analogues, which led to the discovery of compound (R)-27, a novel TRPV1 antagonist with good oral activity in preclinical animal models of pain. (C) 2010 Elsevier Ltd. All rights reserved.